Hanheng Biotechnology

In the name of 'Hanheng', we set sail and gallop in the field of life sciences!
The name 'Hanheng' is derived from Liu Heng, Emperor Wen of the Han Dynasty. During the reigns of Emperor Wen and Emperor Jing, China prospered. Emperor Wen was lenient in temperament, following the will of heaven and the people, allowing the people to rest and recuperate, and dedicating himself to the welfare of all living beings. Hanheng people do not forget the spirit of Emperor Wen and are determined to work diligently in the fields of life sciences and medicine in China.
Hanheng strives to promote the development of gene therapy technology and its clinical translation. Hanheng people are willing to contribute their modest efforts and serve as the backbone!
Founded in 2010, Hanheng Biotechnology is a high-tech enterprise specializing in the research, development, and application of gene technology. It is located in Zhangjiang Hi-Tech Park. Hanheng has always been committed to the research, development, and production of gene vectors. Our core advantageous products include lentivirus, adenovirus, and adeno-associated virus. At the same time, we focus on hot topics, with services including autophagy flux research tools, virus vector-based CRISPR gene editing tools, non-coding RNA, and luciferase experiments. Among them, our self-developed autophagy LC3 double-labeled adenovirus is a gold-standard research tool in the field of autophagy.
So far, viral products have been cited in over 6,000 publications, with nearly 50% of the journals having an impact factor (IF) greater than 5. Among these, Hanheng's autophagy viral products have been cited in over 1,000 academic papers, with an average IF exceeding 6.3, including journals such as Cell, Cancer Cell, Nature Medicine, Autophagy, and Circulation.
In the future, we will build upon our core gene technology and place greater emphasis on translating technology into clinical applications. Hanheng Biotechnology, better gene technology.